FBTIX: Fidelity Advisor® Biotechnology I

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

FBTIX Fidelity Advisor® Biotechnology I


Profile

FBTIX - Profile

Vitals

  • YTD Return -2.0%
  • 3 Yr Annualized Return 6.1%
  • 5 Yr Annualized Return 0.2%
  • Net Assets $2.07 B
  • Holdings in Top 10 64.2%

52 WEEK LOW AND HIGH

$29.06
$25.19
$31.49

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.76%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 62.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $0
  • IRA $500

Fund Classification


Distributions

  • YTD Total Return -2.0%
  • 3 Yr Annualized Total Return 6.1%
  • 5 Yr Annualized Total Return 1.2%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio 0.40%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency None

Fund Details

  • Legal Name
    Fidelity Advisor® Biotechnology Fund
  • Fund Family Name
    Fidelity Investments
  • Inception Date
    Dec 27, 2000
  • Shares Outstanding
    N/A
  • Share Class
    Inst
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Eirene Kontopoulos

Fund Description

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.


Categories

Fund Company Quick Screens

FBTIX - Fund Company Quick Screens


Performance

FBTIX - Performance

Return Ranking - Trailing

Period FBTIX Return Category Return Low Category Return High Rank in Category (%)
YTD -2.0% -10.8% 0.2% 8.66%
1 Yr 1.0% -10.0% 18.7% 69.23%
3 Yr 6.1%* -12.8% 18.6% 29.36%
5 Yr 0.2%* -11.2% 10.3% 24.51%
10 Yr 14.9%* -3.2% 14.9% 1.19%

* Annualized

Return Ranking - Calendar

Period FBTIX Return Category Return Low Category Return High Rank in Category (%)
2019 18.5% 5.7% 55.4% 64.10%
2018 -5.7% -25.3% 21.5% 36.04%
2017 26.2% -10.8% 43.9% 11.01%
2016 -23.4% -31.6% 6.9% 84.91%
2015 6.2% -20.4% 13.8% 8.91%

Total Return Ranking - Trailing

Period FBTIX Return Category Return Low Category Return High Rank in Category (%)
YTD -2.0% -10.8% 0.2% 8.66%
1 Yr 1.0% -10.0% 18.7% 69.23%
3 Yr 6.1%* -12.8% 21.6% 36.70%
5 Yr 1.2%* -11.2% 13.7% 51.96%
10 Yr 16.5%* -3.2% 17.0% 5.95%

* Annualized

Total Return Ranking - Calendar

Period FBTIX Return Category Return Low Category Return High Rank in Category (%)
2019 18.5% 5.7% 55.4% 64.10%
2018 -5.7% -25.3% 22.2% 44.14%
2017 26.2% -10.8% 45.8% 13.76%
2016 -23.4% -26.4% 8.7% 92.45%
2015 11.6% -16.6% 15.2% 16.83%

NAV & Total Return History


Holdings

FBTIX - Holdings

Concentration Analysis

FBTIX Category Low Category High FBTIX % Rank
Net Assets 2.07 B 3.51 M 46.9 B 23.62%
Number of Holdings 65 26 392 76.38%
Net Assets in Top 10 1.42 B 1.14 M 19.7 B 18.11%
Weighting of Top 10 64.17% 21.3% 75.6% 7.09%

Top 10 Holdings

  1. AbbVie Inc 17.61%
  2. Amgen Inc 10.74%
  3. Vertex Pharmaceuticals Inc 9.90%
  4. Alexion Pharmaceuticals Inc 8.03%
  5. Regeneron Pharmaceuticals Inc 5.00%
  6. Ascendis Pharma A/S ADR 3.01%
  7. Neurocrine Biosciences Inc 2.66%
  8. argenx SE ADR 2.52%
  9. Alnylam Pharmaceuticals Inc 2.37%
  10. FibroGen Inc 2.33%

Asset Allocation

Weighting Return Low Return High FBTIX % Rank
Stocks
98.94% 93.77% 103.54% 46.46%
Other
0.58% -27.41% 5.17% 21.26%
Cash
0.49% 0.00% 5.82% 59.84%
Preferred Stocks
0.00% 0.00% 0.91% 80.31%
Convertible Bonds
0.00% 0.00% 1.54% 78.74%
Bonds
0.00% -0.01% 20.60% 80.31%

Stock Sector Breakdown

Weighting Return Low Return High FBTIX % Rank
Healthcare
100.00% 58.44% 100.00% 35.43%
Utilities
0.00% 0.00% 0.00% 77.95%
Technology
0.00% 0.00% 15.59% 78.74%
Real Estate
0.00% 0.00% 5.84% 78.74%
Industrials
0.00% 0.00% 1.93% 79.53%
Financial Services
0.00% 0.00% 5.89% 82.68%
Energy
0.00% 0.00% 0.44% 80.31%
Communication Services
0.00% 0.00% 5.79% 77.95%
Consumer Defense
0.00% 0.00% 36.20% 77.95%
Consumer Cyclical
0.00% 0.00% 5.00% 77.95%
Basic Materials
0.00% 0.00% 2.02% 81.10%

Stock Geographic Breakdown

Weighting Return Low Return High FBTIX % Rank
US
93.73% 59.38% 100.00% 14.96%
Non US
5.21% 0.00% 39.25% 85.83%

Expenses

FBTIX - Expenses

Operational Fees

FBTIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.76% 0.10% 9.84% 90.55%
Management Fee 0.54% 0.09% 1.30% 14.96%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.40% N/A

Sales Fees

FBTIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

FBTIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% 92.68%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FBTIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 62.00% 0.00% 341.00% 83.06%

Distributions

FBTIX - Distributions

Dividend Yield Analysis

FBTIX Category Low Category High FBTIX % Rank
Dividend Yield 0.00% 0.00% 5.56% 81.10%

Dividend Distribution Analysis

FBTIX Category Low Category High Category Mod
Dividend Distribution Frequency None Annually Monthly Annually

Net Income Ratio Analysis

FBTIX Category Low Category High FBTIX % Rank
Net Income Ratio 0.40% -2.24% 2.12% 18.11%

Capital Gain Distribution Analysis

FBTIX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

FBTIX - Fund Manager Analysis

Managers

Eirene Kontopoulos


Start Date

Tenure

Tenure Rank

Jul 15, 2018

1.55

1.6%

Eirene Kontopoulos joined Fidelity Investments in 2007, she has worked as a research analyst and portfolio manager.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.01 22.39 9.98 19.76